In medical monitoring, “overshoot” refers to a device temporarily reading higher or lower than the true value it’s measuring. This happens most often with continuous glucose monitors (CGMs), blood pressure transducers, and heart rate trackers, where the sensor’s response lags behind or exaggerates rapid changes in the body. Understanding overshoot helps you distinguish between a genuine alarm and a device artifact, which matters most when you’re making treatment decisions based on what your monitor displays.
How Overshoot Happens in Medical Monitors
Every medical sensor sits one step removed from the thing it’s actually measuring. A continuous glucose monitor, for example, doesn’t sample blood directly. It reads glucose in interstitial fluid, the liquid between your cells. Blood glucose changes slightly before interstitial fluid glucose does, so when your levels are rising or falling quickly, the sensor reading can lag behind reality, then catch up all at once and briefly exceed the true value. That brief spike past the real number is overshoot.
In blood pressure monitoring, overshoot is a physics problem. Arterial pressure transducers connected through tubing have a natural vibration frequency. When the system is “underdamped,” meaning it doesn’t absorb enough of that vibration, the pressure waveform bounces past the true systolic peak. The result is a falsely elevated blood pressure reading. Devices like the Resonance Over-Shoot Eliminator (ROSE) are specifically designed to increase the damping coefficient of pressure transducer kits without reducing the useful frequency range, essentially smoothing out that artificial bounce.
Why Glucose Monitors Are Most Affected
CGM sensors face a unique combination of error sources. Research dissecting these errors identifies three main components: the diffusion delay as glucose moves from blood into interstitial fluid, calibration drift that shifts readings up or down over time, and random electronic noise layered on top of the signal. Each one can contribute to overshoot, but the diffusion delay is the primary culprit during rapid glucose changes, like after a meal or a correction dose of insulin.
This matters because CGM accuracy standards are built around steady-state conditions. Under the ISO 15197:2013 standard, at least 95% of glucose monitor results must fall within 15 mg/dL of a lab reference at concentrations below 100 mg/dL, and within 15% at concentrations of 100 mg/dL or above. During rapid fluctuations, real-world accuracy can fall outside those bounds temporarily, which is exactly when overshoot is most likely to appear on your screen.
It’s also normal for readings to be less reliable on the first day of a new sensor, when the device is still settling into the tissue. Pressure on the sensor, such as lying on the arm where it’s placed, can also distort readings and mimic overshoot patterns.
The Risk of Reacting to False Readings
The real danger of overshoot isn’t the reading itself. It’s what you do in response. If a glucose monitor briefly overshoots and displays a number 30 or 40 points above your actual blood sugar, you might take a correction dose of insulin you don’t need. That overcorrection can send you into hypoglycemia, a drop in blood sugar that causes shakiness, confusion, and in severe cases, loss of consciousness.
This risk is especially serious for older adults. Research on geriatric diabetes patients found that those who experienced hypoglycemia were on significantly higher insulin doses, averaging 41.6 units compared to 28.3 units in patients without hypoglycemic episodes. The ACCORD trial found that aggressive glucose-lowering led to hypoglycemic events requiring medical help in 10% of patients in the intensive treatment group, compared to 3% in the standard group. That same trial found unexpectedly higher mortality in the intensive group. For older patients with other health conditions, chasing every high reading on a monitor can cause more harm than the high reading itself.
How to Tell Overshoot From a Real Spike
The simplest test is a fingerstick blood glucose reading. Because a standard blood glucose meter samples blood directly rather than interstitial fluid, it isn’t subject to the same diffusion delay. Dexcom’s own troubleshooting guidance recommends using a blood glucose meter to make treatment decisions any time your CGM reading doesn’t match your symptoms or expectations. If your CGM shows a sharp spike but you feel fine and a fingerstick reads normal, overshoot is the likely explanation.
A few patterns can help you spot overshoot before you reach for the meter:
- Timing after meals: A CGM spike that appears unusually sharp 15 to 30 minutes after eating, then drops quickly on its own, often reflects the interstitial fluid “catching up” to a blood glucose change that has already begun resolving.
- First-day sensor behavior: New sensors commonly produce less accurate readings for the first several hours. Spikes during this window deserve extra skepticism.
- Pressure artifacts: If you’ve been sleeping on the sensor or pressing against it, remove the pressure and wait 10 to 15 minutes before trusting the reading.
How Modern Systems Manage Overshoot
Closed-loop insulin delivery systems, sometimes called artificial pancreas systems, are increasingly built to handle overshoot automatically. These devices pair a CGM with an insulin pump and use an algorithm to adjust delivery in real time. The algorithm accounts for the known lag between blood and interstitial glucose, which means it’s less likely to overcorrect based on a transient overshoot than a person making manual decisions would be.
Newer versions of these algorithms are incorporating machine learning to recognize individual patterns. The system can learn, for instance, that your glucose tends to spike sharply after certain types of meals or physical activity, then resolve on its own. Rather than responding aggressively to the peak, it adjusts insulin delivery based on the predicted trajectory. Some systems are also integrating data from additional sensors like heart rate monitors and motion trackers to distinguish exercise-related glucose shifts from dietary ones, further reducing the chance of inappropriate insulin delivery.
For blood pressure monitoring, the engineering solution is more straightforward. Devices like ROSE act as built-in resistors that optimize the damping characteristics of the pressure transducer kit, suppressing the frequencies responsible for waveform overshoot without losing clinically important signal detail. In critical care settings where arterial lines are used, pairing the transducer with a properly calibrated damping device is the standard approach to ensuring the numbers on the screen reflect what’s actually happening in the artery.